53 related articles for article (PubMed ID: 28724284)
21. Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data.
Betancourt LH; Pawłowski K; Eriksson J; Szasz AM; Mitra S; Pla I; Welinder C; Ekedahl H; Broberg P; Appelqvist R; Yakovleva M; Sugihara Y; Miharada K; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Wieslander E; Horvatovich P; Malm J; Jönsson G; Marko-Varga G
Sci Rep; 2019 Mar; 9(1):5154. PubMed ID: 30914758
[TBL] [Abstract][Full Text] [Related]
22. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
Hou Y; Guo H; Guo Y; Zhang Y; Han H
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
[TBL] [Abstract][Full Text] [Related]
23. HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy.
Arora S; Catania R; Borhani A; Horvat N; Fowler K; Harmath C
Abdom Radiol (NY); 2021 Aug; 46(8):3686-3697. PubMed ID: 34195886
[TBL] [Abstract][Full Text] [Related]
24. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract][Full Text] [Related]
25. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
26. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
27. [Serum proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma].
Fu BS; Liu W; Zhang JW; Zhang T; Li H; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1775-8. PubMed ID: 19778787
[TBL] [Abstract][Full Text] [Related]
28. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
[TBL] [Abstract][Full Text] [Related]
29. Radiation oncology in the era of precision medicine.
Baumann M; Krause M; Overgaard J; Debus J; Bentzen SM; Daartz J; Richter C; Zips D; Bortfeld T
Nat Rev Cancer; 2016 Apr; 16(4):234-49. PubMed ID: 27009394
[TBL] [Abstract][Full Text] [Related]
30. Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum.
Gao HJ; Chen YJ; Zuo D; Xiao MM; Li Y; Guo H; Zhang N; Chen RB
Cancer Biol Med; 2015 Sep; 12(3):246-54. PubMed ID: 26487969
[TBL] [Abstract][Full Text] [Related]
31. Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4.
Chandler KB; Brnakova Z; Sanda M; Wang S; Stalnaker SH; Bridger R; Zhao P; Wells L; Edwards NJ; Goldman R
J Proteome Res; 2014 Jul; 13(7):3314-29. PubMed ID: 24884609
[TBL] [Abstract][Full Text] [Related]
32. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma.
Kim KH; Kim MS; Chang JS; Han KH; Kim DY; Seong J
Liver Int; 2014 May; 34(5):784-94. PubMed ID: 24330457
[TBL] [Abstract][Full Text] [Related]
34. Cancer biomarkers.
Henry NL; Hayes DF
Mol Oncol; 2012 Apr; 6(2):140-6. PubMed ID: 22356776
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
